Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Istradefylline in Mild Hepatic Impairment
NCT02256033Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Istradefylline in Parkinson's disease (PD) (2 arms), sponsored by Kyowa Kirin. Primary endpoint: Area under the concentration-time curve at 36 days. Started Aug 2014; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02256033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256033.